|
WO2009074569A1
|
|
Targeting and therapeutic compounds with a polyproline-comprising spacer and gas-filled microvesicles comprising said compounds
|
|
WO2008075192A2
|
|
Targeting and therapeutic compounds and gas-filled microvesicles comprising said com ounds
|
|
US2008063603A1
|
|
Ultrasound contrast agents and methods of making and using them
|
|
WO2007090022A2
|
|
Novel compounds for targeting endothelial cells, compositions containing the same and methods for their use
|
|
US2007128117A1
|
|
Ultrasound contrast agents and process for the preparation thereof
|
|
US2008107607A1
|
|
Targeting vector-phospholipid conjugates
|
|
AU2005271221A1
|
|
An image registration method and apparatus for medical imaging based on mulptiple masks
|
|
US7666979B2
|
|
Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same
|
|
US2004208826A1
|
|
Ultrasound contrast agents and methods of making and using them
|
|
US7385041B2
|
|
Dual functioning excipient for metal chelate contrast agents
|
|
US2004180004A1
|
|
Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
|
|
US2003175211A1
|
|
Ultrasound contrast agents and methods of making and using them
|
|
CA2477935A1
|
|
Multivalent constructs for therapeutic and diagnostic applications
|
|
US2003194376A1
|
|
Ultrasound contrast agents and methods of making and using them
|
|
US2003185759A1
|
|
Ultrasound contrast agents and methods of making and using them
|
|
US2004033243A1
|
|
Sincalide formulations
|
|
US6875864B2
|
|
Aminocarboxylate ligands having substituted aromatic amide moieties
|
|
US2003064027A1
|
|
Ultrasound contrast agents and methods of making and using them
|
|
CA2429781A1
|
|
Linkable sialyl lewis x analogs
|
|
US7160535B2
|
|
Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications
|
